1. Abbott Laboratories. (2006). Protocol No. M01-342: A double-blind, placebo-controlled trial to evaluate the safety and efficacy of Depakote ER for the treatment of mania associated with bipolar disorder in children and adolescents. Retrieved March 31, 2010,
www.clinicalstudyresults.org
.
2. Achenbach, T. M., & Rescorla, L. A. (2001). Manual for the ASEBA school-age forms and profiles. Burlington: University of Vermont.
3. Almandil, N. B., Liu, Y., Murray, M. L., Besag, F. M., Aitchison, K. J., & Wong, I. C. (2013). Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: A systematic review and meta-analysis. Pediatric Drugs, 15(2), 139–150.
4. American Psychiatric Association (APA). (2013). Diagnostic and statistical manual of mental disorders (DSM-5®). Washington, DC: American Psychiatric Association.
5. American Psychological Association. (1993). Task force on promotion and dissemination of psychological procedures. In The meeting of the American Psychological Association.